会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 94. 发明公开
    • 백모증 처리를 위한 엘라그산의 용도
    • 用途用于治疗慢性乙型肝炎
    • KR1020070120906A
    • 2007-12-26
    • KR1020070060436
    • 2007-06-20
    • 로레알
    • 꼬모스테판
    • A61K31/366A61K8/36
    • A61K8/498A61Q5/065
    • An ellagic acid, a salt thereof, a metallic complex thereof, a mono- or poly-ether derivative thereof, a mono- or poly-acyl derivative thereof and a carbonate derivative or carbamate thereof derived from hydroxyl are provided to prevent, limit or stop the progress of canities, and maintain or promote natural re-pigmentation of hair. A cosmetic composition comprises at least one selected from the group consisting of ellagic acid, a salt thereof, a metallic complex thereof, a mono- or poly-ether derivative thereof, a mono- or poly-acyl derivative thereof and a carbonate derivative or carbamate thereof derived from hydroxyl, an agent for controlling desquamating scalp such as selenium disulfide, climbazole, undecylenic acid, ketoconazole, piroctone olamine, and cyclo piroctone, and/or a plant extract having propigmenting activity in a cosmetically acceptable medium. A method for cosmetically treating canities comprises a step of orally administering at least one compound selected from the group consisting of ellagic acid, a salt thereof, a metallic complex thereof, a mono- or poly-ether derivative thereof, a mono- or poly-acyl derivative thereof and a carbonate derivative or carbamate thereof derived from hydroxyl or topically applying the compound to a portion in need thereof.
    • 提供鞣花酸,其盐,其金属络合物,其单醚或多醚衍生物,其衍生自羟基的单酰基或多酰基衍生物和碳酸酯衍生物或氨基甲酸酯,以防止,限制或停止 保护或促进头发的自然再色素沉淀。 化妆品组合物包含选自鞣花酸,其盐,其金属络合物,其单醚或聚醚衍生物,其单 - 或多酰基衍生物和碳酸酯衍生物或氨基甲酸酯中的至少一种 衍生自羟基的化合物,用于控制脱屑性头皮的药剂如二硫化硒,攀摩唑,十一碳烯酸,酮康唑,吡罗酮醇和环焦糖,和/或在化妆品可接受的培养基中具有辅助活性的植物提取物。 美容治疗方法的方法包括口服给予选自鞣花酸,其盐,其金属络合物,其一元或多醚衍生物,单 - 或多 - 酰基衍生物和衍生自羟基的碳酸酯衍生物或氨基甲酸酯,或将化合物局部施用于有需要的部分。
    • 95. 发明公开
    • 피부 미백 방법, 조성물 및 제품
    • 皮肤照射方法,组合物和产品
    • KR1020070116026A
    • 2007-12-06
    • KR1020077022106
    • 2006-03-17
    • 지보당 에스아
    • 나츠쉬안드레아스와세샤미카엘
    • A61K8/35A61K8/33A61K8/34A61Q19/02
    • A61K8/34A61K8/33A61K8/347A61K8/35A61K8/40A61K8/411A61K8/4973A61K8/498A61Q13/00A61Q19/02
    • The invention relates to methods of cosmetic lightening the human skin, compounds and perfume compositions that have a skin lightening effect and personal care products for application to the human skin comprising such skin lightening compounds and perfume compositions. A number of compounds not known before to have a skin lightening effect were identified. These skin lightening compounds provide the perfumer with a larger palette of fragrance notes and provide more possibilities to create desired fragrance accords in skin lightening perfume compositions and skin lightening personal care products. Skin lightening perfume compositions and skin lightening personal care products according to the invention comprise at least one of the identified fragrant skin lightening compounds.
    • 本发明涉及化妆品化妆品的化妆品,其具有皮肤增亮效果的化妆品,化妆品和香料组合物以及用于人皮肤的个人护理产品,其包含这些皮肤增亮化合物和香料组合物。 鉴定了许多以前不知道具有皮肤增亮作用的化合物。 这些皮肤增亮化合物为香料师提供了更大的香味调色剂,并提供更多的可能性,以在皮肤增亮香水组合物和皮肤增亮个人护理产品中产生所需的香料。 根据本发明的皮肤增亮香水组合物和皮肤增亮个人护理产品包含至少一种所鉴定的香味皮肤发亮化合物。
    • 99. 发明公开
    • 이카린의 가수분해물을 함유하는 화장료용 조성물
    • 含有ICARIIN水解物的化妆品组合物
    • KR1020070056674A
    • 2007-06-04
    • KR1020050115649
    • 2005-11-30
    • (주)아모레퍼시픽
    • 박준성노호식김덕희장이섭
    • A61K8/49A61Q19/10A61Q19/02
    • A61K8/498A61K8/602A61K2800/522A61Q19/02A61Q19/08
    • A cosmetic composition comprising a hydrolysate of icariin is provided to show anti-aging effect and melanogenesis inhibition effect through expression inhibition effect, and whitening effect through improving pigmentation generated by UV, thereby being usefully used as a cosmetic composition or a pharmaceutical composition for anti-aging, whitening and wrinkle improving. The cosmetic composition comprises a hydrolysate of icariin represented by the formula(1), wherein R1 is OH or rhamnopyranose and R2 is OH or glucopyranose, provided that both R1 and R2 are not simultaneously rhamnopyranose and glucopyranose. The hydrolysate of icariin is prepared by extracting a plant using water or an organic solvent to obtain a plant extract and then hydrolyzing the plant extract using an acid, a base, an enzyme or a microorganism producing the enzyme.
    • 提供含有淫羊藿苷水解产物的化妆品组合物,以通过表达抑制作用显示出抗衰老作用和黑素生成抑制作用,以及通过改善由UV产生的色素沉着的美白效果,从而可有效地用作化妆品组合物或抗癌药物组合物, 老化,美白和皱纹改善。 化妆品组合物包含由式(1)表示的淫羊a a水解物,其中R1是OH或吡喃糖吡喃糖,R2是OH或吡喃葡萄糖,条件是R1和R2都不是同时具有吡喃葡萄糖和吡喃葡萄糖。 通过使用水或有机溶剂提取植物来获得植物提取物,然后使用产生该酶的酸,碱,酶或微生物水解植物提取物来制备淫羊茸的水解产物。
    • 100. 发明公开
    • 메로시아닌 유도체
    • 月桂酰胺衍生物
    • KR1020070026590A
    • 2007-03-08
    • KR1020067026302
    • 2005-06-20
    • 시바 홀딩 인코포레이티드
    • 바그너바르바라비에네발트프랑크볼레프하인츠발퀴스트올로프헤르조크베른트엘리스토마스하제쥐르크
    • A61K8/81A61Q17/04
    • A61K8/498A61K8/4913A61K8/494A61Q17/04
    • Disclosed is the use of merocyanine derivatives of formula (I), wherein Q is hydrogen; C1-C22alkyl; -OH; -OR7; -NR7R8; or -N=R9; R1 is hydrogen; C1-C22alkyl; -OR7, -SR7; -NR7R8; C1-C22alkyl; C2-C12alkenyl; C2-C12alkinyl; C3-C12cycloalkyl; C3-C12cycloalkenyl; C7-C12aralkyl; C1-C12heteroalkyl, C2-C11heteroaralkyl; C6-C10aryl; or C1-C9heteroaryl; R4 is cyano; COR7, COOR7; CONR7R8; SO2(C6-C12)aryl; C2-C12alk-1-enyl; C3-C12cycloalk-1-enyl; C2-C12alk-1-inyl; C2-C12heteroalkyl; C3-C5heterocycloalkyl; C6-C10aryl; or C1-C9heteroaryl; R5 is -COR7; -COOR7; -OR7; -SR7, -NHR7, -NR7R8; C1-C22alkyl; C2-C12alkenyl; C2-C12alkinyl; C3-C12cycloalkyl; C3-C12cycloalkenyl; C7-C12aralkyl; C1-C12alkylphenyl; C1-C12alkoxy-C6-C10aryl; C1-C12heteroalkyl; C2-C11heteroaralkyl; C3-C12cycloheteroalkyl; C6-C10aryl; C1- C12alkoxy-C6-C10aryl; or C1-C9heteroaryl; R6 is hydrogen; C1-C22alkyl; C1-C22alkoxy; or COR7; R7 and R8 independently from each other are hydrogen; C1-C22alkyl; C2-C12alkenyl; C2-C12alkinyl; C3-C12cycloalkyl; C3-C12cycloalkenyl; -(CH2)tCOOH; C7-C12aralkyl; C1-C12heteroalkyl; C2-C11heteroaralkyl; C6-C10aryl; C1-C9heteroaryl; Si-R10R11R12; Si(OR10)(OR11)(OR12); SiR10(OR11)(OR12); SiR10R11(OR12); -(CH2)u-O-(CH2)v-SiR10R11R12; or a radical X-Sil; t, u and v, independently from each other are a number from 1 to 5; R9 is a (C1-C6)alkylidene radical; R10, R11, R12 independently form each other are C1-C22alkyl; X is a linker; Sil is a silane-, oligosiloxane- or polysiloxane radical; R1 and R2, R1 and Q, R1 and R6, R1 and T, R2 and R3, R2 and R4, R2 and R6, R2 and Q, R4 and R6, R4 and T, R6 and Q, T and Q, each independently, are linked together, so that 1, 2, 3 or 4 carbocyclic or N, O and/or S-heterocyclic rings are formed, wherein each of them, independently from each other, may be condensed with an aromatic or heteroaromatic ring, and/or more N-, O- and/or S-heterocyclic rings, and each N atom in a N-heterocyclic ring may be substituted by C1-C22alkyl; n is a number from 1 to 4; wherein at least one of the radicals R1, R6 or Q is different from hydrogen; if n = 1 T is -COR5; -CN; C6-C10aryl; -NHR5; or -SO2-(C6-C12)aryl; R2 and R3 independently from each other are C1-C22alkyl; hydroxy-C1-C22alkyl; C2-C12alkenyl; C2-C12alkinyl; C3-C12cycloalkyl, C3-C12cycloalkenyl; C7-C12aralkyl; C1-C12heteroalkyl; C3-C12cycloheteroalkyl; C6-C10aryl; C1-C9heteroaryl; or a radical of formula (II); p is a number from 5 to 100; q is a number from 1 to 5; s is a number from 0 to 4; if n = 2 R2 and R3 are each C1-C5alkylene; and simultaneously T is defined as for n = 1; or T is a bivalent radical of formula -NR7-V-NR7-, wherin V is phenylene; or C1-C5alkylene; R7 is hydrogen; or C1-C5alkyl; and R2 and R3 simultaneously are defined as for n = 1; if n = 3 one of R2, R3 or T is a trivalent radical; if n = 4 one of R2, R3 or T is a tetravalent radical; for protecting of human hair and skin against the damaging effect of UV radiation. ® KIPO & WIPO 2007
    • 公开了式(I)的部花青衍生物的用途,其中Q是氢; C1-C22烷基; -哦; -OR7; -NR7R8; 或-N = R 9; R1是氢; C1-C22烷基; -OR7,-SR7; -NR7R8; C1-C22烷基; C2--C 12烯; C2-C12alkinyl; C3-C12环烷基; C3-C12cycloalkenyl; C7-C12aralkyl; C 1 -C 12杂烷基,C 2 -C 11杂芳烷基; C6-C10芳基; 或C 1 -C 9杂芳基; R4是氰基; COR7,COOR7; CONR7R8; SO2(C6-C12)芳基; C2-C12alk -1-烯基; C3-C12cycloalk -1-烯基; C2-C12alk -1-炔; C2-C12heteroalkyl; C3-C5heterocycloalkyl; C6-C10芳基; 或C 1 -C 9杂芳基; R5为-COR7; -COOR7; -OR7; -SR 7,-NHR 7,-NR 7 R 8; C1-C22烷基; C2--C 12烯; C2-C12alkinyl; C3-C12环烷基; C3-C12cycloalkenyl; C7-C12aralkyl; C1-C12alkylphenyl; C1-C12烷氧基,C6-C10芳基; C1-C12heteroalkyl; C2-C11heteroaralkyl; C3-C12cycloheteroalkyl; C6-C10芳基; C 1 -C 12烷氧基-C 6 -C 10芳基; 或C 1 -C 9杂芳基; R6是氢; C1-C22烷基; C1-C22alkoxy; 或COR7; R 7和R 8彼此独立地是氢; C1-C22烷基; C2--C 12烯; C2-C12alkinyl; C3-C12环烷基; C3-C12cycloalkenyl; - (CH2)tCOOH; C7-C12aralkyl; C1-C12heteroalkyl; C2-C11heteroaralkyl; C6-C10芳基; C1-C9heteroaryl; 的Si-R10R11R12; 的Si(OR 10)(OR 11)(OR 12); SiR10(OR11)(OR12); SiR10R11(OR12); - (CH 2)u-O-(CH 2)V-SiR10R11R12; 或基团X-Sil; t,u和v彼此独立地为1至5的数; R9是(C1-C6)亚烷基; R 10,R 11,R 12彼此独立地为C 1 -C 22烷基; X是一个连接子; Sil是硅烷,低聚硅氧烷或聚硅氧烷基团; R1和R2,R1和Q,R1和R6,R1和T,R2和R3,R2和R4,R2和R6,R2和Q,​​R4和R6,R4和T,R6和Q,T和Q各自独立 形成1,2或3或4个碳环或N,O和/或S-杂环,其中它们彼此独立地可以与芳族或杂芳族环稠合,并且 /或更多的N,O-和/或S-杂环,并且N-杂环中的每个N原子可以被C 1 -C 22烷基取代; n是从1到4的数字; 其中基团R1,R6或Q中的至少一个不同于氢; 如果n = 1,则T为-COR 5; -CN; C6-C10芳基; -NHR 5; 或-SO 2 - (C 6 -C 12)芳基; R2和R3彼此独立地为C1-C22烷基; 羟基C1-C22烷基; C2--C 12烯; C2-C12alkinyl; C3-C12环烷基,C3-C12环烯基; C7-C12aralkyl; C1-C12heteroalkyl; C3-C12cycloheteroalkyl; C6-C10芳基; C1-C9heteroaryl; 或式(II)的基团; p是从5到100的数字; q是从1到5的数字; s是从0到4的数字; 如果n = 2,R 2和R 3各自为C 1 -C 5亚烷基; 并且同时T定义为n = 1; 或T是式-NR7-V-NR7-的二价基团,V是亚苯基; 或C 1 -C 5亚烷基; R7是氢; 或C 1 -C 5烷基; R2和R3同时定义为n = 1; 如果n = 3,R 2或R 3中的一个为三价基团; 如果n = 4,R2,R3或T是四价基团; 用于保护人的头发和皮肤免受紫外线辐射的破坏作用。 ®KIPO&WIPO 2007